ParkinsonNet has receives a Parel award by The Economic Board. ParkinsonNet aims to improve the lives of people affected by Parkinson. The Parel award goes to companies and organizations that distinguish themselves through innovation, and aims to raise awareness for them.
The results achieved by ParkinsonNet did not go unnoticed outside of the Netherlands: several networks have come into existence around the organization. Moreover, it has begun to cooperate with the life science company Verily.
"We are very happy with the Parel award, as it reflects recognition for the economical value of ParkinsonNet by a third, unrelated party. That is not our goal, but it furthers our ambition to help people across the globe and to foster collaboration with private parties."
The Parel award and The Economic Board
Started in 2016, this has been the second time that the Parel awards were awarded by The Economic Board. This year it was also awarded to Kraft Heinz and Allego. The Parel award distinguishes companies and organizations that, in the view of The Economic Board, excel through innovation.
The Economic Board is a Triple Helix collaboration between the state, research institutes, and private companies in the region Arnhem - Nijmegen and the city of Wageningen. This part of the Netherlands is considered a bulwark for food, health care, energy, and the corresponding state-of-the-art research. It is the intent of The Economic Board to communicate the potential of this region and to bring together entrepeneurs, investors, education, research, and the state.
-
Want to know more about these subjects? Click on the buttons below for more news.
Related news items

Grants for science communication at Radboudumc
22 April 2021 Scientists at the Radboudumc have received two KNAW grants, each worth 10,000 euros, for science communication. With the new fund, KNAW underlines importance of making science accessible. read more
UMD Catalist grant for Mohammad Alsady and Federica Conte
24 June 2020They received this award to explore the potential of hiPS-derived skeletal muscle cells as model to investigate muscular pathophysiologic mechanisms in phosphoglucomutase I deficiency.
read more
Bas Bloem elected as new member of the KNAW
30 April 2020 Bas Bloem is an expert in Parkinson's disease. He is also a healthcare innovator, focused on the integration of scientific research and its clinical applications. We congratulate Bas with this election. read more
Towards molecular therapies for Myotonic Dystrophy
1 October 2019ReCognitION, a new 1.3 M€ European project under the leadership of Peter-Bram ‘t Hoen, Baziel van Engelen and Jeffrey Glennon, was kicked-off in Gent.
read more
Useful new test for Parkinson's disease
28 March 2019 Diagnosing Parkinson's is not easy. In particular in the early stages, it can be difficult to distinguish Parkinson's from a group of other disorders that at first sight look identical. read more